Activation of AMPA and kainate glutamate receptors impairs the viability of oligodendrocytes in vitro.
Sanchez-Gomez
M V
MV
Departamento de Neurociencias, Facultad de Medicina y Odontología, Universidad del País Vasco, Leioa, Spain.
Matute
C
C
D018750:6-Cyano-7-nitroquinoxaline-2,3-dione / Q000494:pharmacology; D000818:Animals; D002470:Cell Survival / Q000502:physiology; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D066298:In Vitro Techniques; D007608:Kainic Acid / Q000494:pharmacology; D009836:Oligodendroglia / Q000166:cytology*; D009900:Optic Nerve / Q000166:cytology / Q000378:metabolism; D011487:Protein Conformation; D051381:Rats; D018091:Receptors, AMPA / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D018092:Kainic Acid Receptors / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid / Q000494:pharmacology
D018750:6-Cyano-7-nitroquinoxaline-2,3-dione; D018690:Excitatory Amino Acid Agonists; D018691:Excitatory Amino Acid Antagonists; D007608:Kainic Acid; D018091:Receptors, AMPA; D018092:Kainic Acid Receptors; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid